Canada markets open in 5 hours 43 minutes

CytoDyn Inc. (CYDY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1390+0.0034 (+2.51%)
At close: 03:54PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-05-31
2022-05-31
2021-05-31
2020-05-31
Total Revenue
0
0
266
0
0
Cost of Revenue
0
20,633
73,543
0
0
Gross Profit
0
-20,633
-73,277
0
0
Operating Expenses
Research Development
4,624
2,632
27,043
53,403
52,640
Selling General and Administrative
10,545
17,136
44,303
34,320
19,973
Total Operating Expenses
15,204
19,943
72,127
89,520
74,647
Operating Income or Loss
-15,204
-40,576
-145,404
-89,520
-74,647
Interest Expense
6,045
6,750
15,066
61,031
32,412
Total Other Income/Expenses Net
-7,005
-8,750
-3,853
-25,704
-32,042
Income Before Tax
-51,690
-79,824
-210,820
-176,465
-139,936
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-51,690
-79,824
-210,820
-176,465
-139,936
Net Income
-51,690
-79,824
-210,820
-176,465
-139,936
Net Income available to common shareholders
-53,174
-86,736
-212,448
-178,152
-140,644
Basic EPS
-0.08
-0.10
-0.31
-0.30
-0.33
Diluted EPS
-0.08
-0.10
-0.31
-0.30
-0.33
Basic Average Shares
870,461
836,528
676,900
587,590
421,078
Diluted Average Shares
870,461
836,528
676,900
587,590
421,078